New Heart Failure Drug Shows Little Benefit
A new study published in JAMA found neladenoson bialanate did not improve exercise capacity among patients suffering from heart failure with preserved ejection fraction.
Browsing: Clinical Breakthroughs
Drug Shows Benefit for Osteoarthritis Patients
A drug called tanezumab reduced pain and improved physical function in patients with osteoarthritis, although more research on safety is needed, according to a study published in JAMA.
Vitamin D Supplements and Risk of Type 2 Diabetes
Daily vitamin D supplements did not significantly reduce the risk of Type 2 diabetes among adults at high risk for the disease, according to a large clinical trial published in The New England Journal of Medicine.
Pink Noise Boosts Deep Sleep in Mild Cognitive Impairment Patients
Gentle sound stimulation played during deep sleep enhanced deep or slow-wave sleep for people with mild cognitive impairment, who are at risk for Alzheimer’s disease, according to a Northwestern Medicine study.
Restrictions on Electronic Medical Records Show Little Benefit
Restricting physicians’ ability to view multiple patient records at the same time did not reduce wrong-patient orders, according to a large clinical trial published in JAMA.
Self-Management Intervention Improves Asthma Outcomes in Older Adults
A targeted intervention to support asthma self-management significantly improved outcomes and medication adherence among older adults with asthma, according to a new study published in JAMA Internal Medicine.
Many Preventive Antibiotics Prescribed by Dentists Are Unnecessary
More than 80 percent of antibiotics prescribed before dental procedures to prevent infection are unnecessary, according to a study published in JAMA Network Open.
Radiation Plus Chemotherapy Doesn’t Improve Endometrial Cancer Recurrence-Free Survival
In a surprising new finding, radiation combined with chemotherapy did not increase recurrence-free survival in women with stage III/IVA endometrial cancer following surgery.
Standard Treatment May Not Benefit Many Patients With Mild Asthma
Many patients with mild asthma may not benefit from inhaled steroid medications, the current standard treatment, according to a clinical trial published in the New England Journal of Medicine.
Drug Improves Survival in Relapsed Chronic Lymphocytic Leukemia
A combination of idelalisib and rituximab is an effective and safe treatment for patients with relapsed chronic lymphocytic leukemia, according to the results of a phase III clinical trial.